- Home
- Publications
- Publication Search
- Publication Details
Title
Therapy for Mycobacterium kansasii Infection: Beyond 2018
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-09-24
DOI
10.3389/fmicb.2018.02271
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
- (2018) Zofia Bakuła et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine for the treatment of Mycobacterium kansasii
- (2018) Shashikant Srivastava et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis
- (2018) Nicole C. Ammerman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- Comparative In vitro Activities of Several Oxazolidinones against Mycobacterium kansasii
- (2018) C. Shoen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Mycobacteria in Municipal Wastewater Treatment and Reuse: Microbial Diversity for Screening the Occurrence of Clinically and Environmentally Relevant Species in Arid Regions
- (2017) Yamrot M. Amha et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- (2017) Charles S Haworth et al. THORAX
- Pulmonary disease by non-tuberculous mycobacteria – clinical management, unmet needs and future perspectives
- (2017) Lars-Olof Larsson et al. Expert Review of Respiratory Medicine
- Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
- (2017) Sarah A McGuffin et al. Open Forum Infectious Diseases
- Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria
- (2016) Isha Soni et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China
- (2016) Yanming Li et al. Frontiers in Microbiology
- Rapid Drug Tolerance and Dramatic Sterilizing Effect of Moxifloxacin Monotherapy in a Novel Hollow-Fiber Model of Intracellular Mycobacterium kansasii Disease
- (2015) Shashikant Srivastava et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
- (2015) Sandeep Tyagi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
- (2013) Wouter Hoefsloot et al. EUROPEAN RESPIRATORY JOURNAL
- Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
- (2012) Emily R. Driver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
- (2012) B. A. Brown-Elliott et al. CLINICAL MICROBIOLOGY REVIEWS
- In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
- (2012) Shashikant Srivastava et al. CURRENT PHARMACEUTICAL DESIGN
- Clofazimine: current status and future prospects
- (2011) M. C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection
- (2010) D. Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
- (2009) M. Santin et al. EUROPEAN RESPIRATORY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now